Efficacy of Autologous Growth Factors Application in Musculo-Skeletal System Injuries and Diseases



Cite item

Full Text

Abstract

Literature review on the assessment of the efficacy of platelet rich autoplasma for the treatment of various musculo-skeletal system diseases - tendinopathy, osteoarthrosis, injuries of ligaments, tendons, muscles and bones is presented. Platelet rich autoplasma contains growth factors and secretory proteins that can start up remodeling and restorative processes in pathologic tissues. The method showed itself to be effective, safe, free from side effects and complications. Most of the research workers consider it reasonable to conduct randomized controlled studies in order to receive reliably data on this methods efficacy.

About the authors

S. P Mironov

Central Institute of Traumatology and Orthopaedics named after N.N. Priorov, Moscow, Russia

A. A Ochkurenko

Central Institute of Traumatology and Orthopaedics named after N.N. Priorov, Moscow, Russia

G. A Kesyan

Central Institute of Traumatology and Orthopaedics named after N.N. Priorov, Moscow, Russia

S. N Savel’ev

City Hospital № 1, Glazov, Russia

Email: alsavel@mail.ru

A. A Arkad’ev

City Hospital № 1, Glazov, Russia

N. N Zbarag

City Hospital № 1, Glazov, Russia

References

  1. Woolf A.D., Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003; 81: 646-56.
  2. WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 2003; 919: i-x, 1-218, back cover.
  3. Leveille S.G. Musculoskeletal aging. Curr. Opin. Rheumatol. 2004; 16: 114-18.
  4. Петрунько И.Л. Заболеваемость, инвалидность вследствие болезней костно-мышечной системы, их медико-социальная значимость и научное обоснование системы реабилитации инвалидов: Автореф. дисс. … д-ра мед. наук. М.; 2011.
  5. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-Rich Plasma. Am J. Sports Med. 2009; 37: 2259
  6. Eppley B.L., Woodell J.E., Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast. Reconstr. Surg. 2004; 114 (6): 1502-8.
  7. Gordin K. Comprehensive scientific overview on the use of Platelet Rich Plasma Prolotherapy (PRPP). J. Prolotherapy. 2011; 3 (4): 813-25.
  8. Kon E., Filardo G., Delcogliano M. Fini M., Salamanna F., Giavaresi G. et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet. Disord. 2010; 27 (11): 220.
  9. Pietrzak W., Eppley B.L. Scientific foundations platelet rich plasma: biology and new technology. J. Craniofac. Surg. 2005; 16 (6): 1043-54.
  10. Самодай В.Г., Брехов В.Л., Гайдуков В.Е., Рыльков М.И. Способ получения богатой тромбоцитами аутоплазмы. Патент РФ №2305563; 2007.
  11. Weibrich G., Kleis W.K. Curasan PRP kit vs. PCCS PRP system: collection efficiency and platelet counts of two different methods for the preparation of platelet rich plasma. Clin. Oral Implant. Res. 2002; 13: 437-43.
  12. Кесян Г.А., Берченко Г.Н., Уразгильдеев Р.З., Микелаишвилли Д.С., Арсеньев И.Г., Шайкевич А.В., Кондратьева И.Е. Использование коллапана с аутологичными факторам роста для стимуляции процессов регенерации. В кн.: Сборник работ 2-й Всероссийской научно-практической конференции. «Применение искусственных кальций-фосфатных материалов в травматологии и ортопедии» М.; 2011: 23-4.
  13. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin. Oral Implant. Res. 2006; 1: 212-9.
  14. Dugrillon A., Eichler H., Kern S., Kluter H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int. J. Oral Maxillofac. Surg. 2002; 31: 615-9.
  15. Nagata M.J., Messora M.R., Furlaneto F.A., Fucini S.E., Bosco A.F., Garcia V.G. et al. Effectiveness of two methods for preparation of autologous platelet-rich plasma: an experimental study in rabbits. Eur. J. Dent. 2010; 4 (4): 395-402.
  16. Sundman E.A., Cole B.J., Fortier L.A. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 2011; 39 (10): 2135-40.
  17. McCarrel T.M., Minas T., Fortier L.A. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J. Bone Joint Surg. Am. 2012; 94 (19): e143(1-8).
  18. Ferrari M., Zia S., Valbonesi M., Henriquet F., Venere G., Spagnolo S. et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intra-operative blood salvage in cardiac surgery. Int. J. Artif. Organs. 1987; 10: 47-50.
  19. Vacanti J., Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet. 1999; 354: 32-4.
  20. Marx R., Garg A.K. Dental and craniofacial applications of platelet rich plasma. Carol Stream: Quintessen Publishing Co, Inc.; 2005.
  21. Anitua E., Andía I., Sanchez M., Azofra J., del Mar Zalduendo M., de la Fuente M. et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J. Orthop. Res. 2005; 23 (2): 281-6.
  22. Anitua E., Sanchez M., Nurden A.T., Zalduendo M.M., de la Fuente M., Azofra J., Andia I. Platelet-released growth factors enhance the secretion of hyaluronic acid and leads hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology. 2007; 46 (12): 1769-72.
  23. Murray M.M., Spindler K.P., Abreu E., Muller J.A., Nedder A., Kelly M. et al. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J. Orthop. Res. 2007; 25 (1): 81-91.
  24. Lyras D., Kazakos K., Verettas D., Polychronidis A., Simopoulos C., Botaitis S. et al. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int. Orthop. 2010; 34 (1): 143-8.
  25. Sun Y., Feng Y., Zhang C.Q., Chen S.B., Cheng X.G. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int. Orthop. 2010; 34 (4): 589-97.
  26. van Buul G.M., Koevoet W.L., Kops N., Bos P.K., Verhaar J.A, Weinans H., Bernsen M.R., van Osch G.J. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 2011; 39 (11): 2362-70.
  27. Кесян Г.А., Берченко Г.Н., Нахапетян Т.Г., Гаврюшенко Н.С., Уразгильдеев Р.З., Микелаишвилли Д.С., Арсеньев И.Г., Мурадян Д.Р., Дан И.М. Экспериментально-морфологическое и клиническое обоснование применения аутотромбоцитарных факторов. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2012; 4: 32-7.
  28. Bosch G., van Schie H.T., de Groot M.W., Cadby J.A., van de Lest C.H., Barneveld A., van Weeren P.R. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study. J. Orthop. Res. 2010; 28 (2): 211-7.
  29. Filardo G., Kon E., Della Villa S., Vincentelli F., Fornasari P.M., Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int. Orthop. 2010; 34 (6): 909-15.
  30. Gosens T., Den Oudsten B.L., Fievez E., van 't Spijker P, Fievez A. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int. Orthop. 2012; 36 (9): 1941-6.
  31. Vetrano M., Castorina A., Vulpiani M.C., Baldini R., Pavan A., Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am. J. Sports Med. 2013; 41(4):795-803.
  32. Kon E., Buda R., Filardo G., Di Martino A., Timoncini A., Cenacchi A. et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg. Sports Traumatol Arthrosc. 2010; 18 (4): 472-9.
  33. Sampson S., Reed M., Silvers H., Meng M., Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am. J. Phys. Med. Rehabil. 2010; 89 (12): 961-9.
  34. Spaková T., Rosocha J., Lacko M., Harvanová D., Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am. J. Phys. Med. Rehabil. 2012; 91 (5): 411-7.
  35. Cerza F., Carnì S., Carcangiu A., Di Vavo I., Schiavilla V., Pecora A. et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am. J. Sports Med. 2012; 40 (12): 2822-7.
  36. Gobbi A., Karnatzikos G., Mahajan V., Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012; 4 (2): 162-72.
  37. Peerbooms J.C., Sluimer J., Bruijn D.J., Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am. J. Sports Med. 2010; 38 (2): 255-62.
  38. Creaney L., Wallace A., Curtis M., Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br. J. Sports Med. 2011; 45 (12): 966-71.
  39. Thanasas C., Papadimitriou G., Charalambidis C., Paraskevopoulos I., Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am. J. Sports Med. 2011; 39 (10): 2130-4.
  40. Barrett S., Erredge S. Growth factors for chronic plantar fascitis. Podiatry Today. 2004; 17: 37-42.
  41. Martinelli N., Marinozzi A., Carnì S., Trovato U., Bianchi A., Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int. Orthop. 2013; 37 (5): 839-42.
  42. Башкина А.С., Широкова Л.Ю., Князева Т.С., Паруля О.М., Абросимова Е.Б., Носков С.М. Применение обогащенной тромбоцитами плазмы в купировании болевого синдрома большого вертела. Травматология и ортопедия России. 2011; 2: 57-61.
  43. Sánchez M., Anitua E., Azofra J., Andía I., Padilla S., Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am. J. Sports Med. 2007; 35 (2): 245-51.
  44. Gaweda K., Tarczynska M., Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int. J. Sports Med. 2010; 31 (8): 577-83.
  45. Гайдуков В.Е. Хирургическое лечение несросшихся переломов и ложных суставов с использованием богатой тромбоцитами аутоплазмы: Автореф.. дис. канд. мед. наук. Воронеж; 2009.
  46. Кесян Г.А., Берченко Г.Н., Уразгильдеев Р.З., Микелаишвили Д.С., Шулашов Б.Н. Сочетанное применение обогащенной тромбоцитами аутоплазмы и биокомпозиционного материала Коллапан в комплексном лечении больных с длительно несрастающимися переломами и ложными суставами длинных костей конечностей. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2011; 2: 26-32.
  47. Guadilla J., Fiz N., Andía I., Sánchez M. Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip. Knee Surg. Sports Traumatol. Arthrosc. 2012; 20 (2): 393-8.
  48. Wei L.C., Lei G.H., Sheng P.Y., Gao S.G., Xu M., Jiang W. et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra- articular calcaneal fractures: a prospective cohort study. J. Orthop. Res. 2012; 30 (10): 1570-6.
  49. Antiua E., Sanchez M., Nurden A.T., Zalduendo M., de la Fuente M., Orive G. et al. Autologous fibrin matrices potential source of biological mediators that modulate tendon cell activities. J. Biomed. Mater. Res. A. 2006; (2): 285-93.
  50. Наговицин Е.С. Осложнения после местного применения гидрокортизона. Клиническая хирургия. 1977; 3: 51-3.
  51. Ситник А.А. Разрыв ахиллова сухожилия после ведения кортикостероидов (обзор литературы и сообщение о 3 случаях). Медицинский журнал. 2003; 4: 22-4.
  52. Sampson S., Gerhardt M., Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr. Rev. Musculoskelet. Med. 2008; 1 (3-4): 165-74.
  53. Alternative treatments: dealing with chronic pain. Mayo Clinic Health Letter. 2005; 23 (4): 1-3.
  54. Everts P., Knape J., Weirich G., Schonberger J., Hoffman J., Overdevest E. et al. Platelet-rich plasma and platelet gel: a review. JECT. 2006; 38: 174-87.
  55. Froum S., Wallace S.S., Tarnow D.P., Cho S.C. Effect of platelet rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int. J. Periodont. Restor. Dent. 2002; 22: 45-53.
  56. Jensen T.B., Rahbek O., Overgaard S., Søballe K. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J. Orthop. Res. 2004; 22 (3): 653-8.
  57. Schepull T., Kvist J., Norrman H., Trinks M., Berlin G., Aspenberg P. Autologous platelets have no effect on the healing of human achilles tendon ruptures: a randomized single-blind study. Am. J. Sports Med. 2011; 39 (1): 38-47.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-76249 от 19.07.2019.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies